Charles Schwab
DTIL icon

Charles Schwab’s Precision BioSciences DTIL Stock Holding History

Charles Schwab’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Buy
78,327
+58,327
+292% +$410K ﹤0.01% 3179
2026
Q1 		$110K Buy
+20,000
New +$92.3K ﹤0.01% 3370
2023
Q3 		– Sell
-1,709
Closed -$27K – 3588
2023
Q2 		$27K Hold
1,709
– – ﹤0.01% 3524
2023
Q1 		$38.6K Hold
1,709
– – ﹤0.01% 3388
2022
Q4 		$61K Hold
1,709
– – ﹤0.01% 3322
2022
Q3 		$67K Sell
1,709
-5,499
-76% -$261K ﹤0.01% 3265
2022
Q2 		$346K Sell
7,208
-4,874
-40% -$286K ﹤0.01% 3170
2022
Q1 		$1.12M Buy
12,082
+428
+4% +$58.2K ﹤0.01% 2810
2021
Q4 		$2.59M Buy
11,654
+539
+5% +$151K ﹤0.01% 2617
2021
Q3 		$3.85M Buy
11,115
+523
+5% +$177K ﹤0.01% 2491
2021
Q2 		$3.98M Buy
10,592
+629
+6% +$189K ﹤0.01% 2457
2021
Q1 		$3.09M Buy
9,963
+219
+2% +$76.7K ﹤0.01% 2527
2020
Q4 		$2.44M Buy
9,744
+216
+2% +$52.9K ﹤0.01% 2539
2020
Q3 		$1.76M Buy
9,528
+5,232
+122% +$1.04M ﹤0.01% 2536
2020
Q2 		$1.07M Buy
4,296
+677
+19% +$148K ﹤0.01% 2603
2020
Q1 		$655K Buy
3,619
+11
+0.3% +$2.88K ﹤0.01% 2616
2019
Q4 		$1.5M Buy
3,608
+1,924
+114% +$605K ﹤0.01% 2486
2019
Q3 		$424K Buy
1,684
+83
+5% +$27K ﹤0.01% 2867
2019
Q2 		$637K Buy
+1,601
New +$645K ﹤0.01% 2717

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Charles Schwab's DTIL Position: Q2 2026 in Review

Charles Schwab increased its Precision BioSciences (DTIL) stake by 292% in Q2 2026, buying an estimated $410K and bringing the position to 78,327 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.

Charles Schwab first reported a position in DTIL in Q2 2019 and has held it in 19 quarters since. The position peaked at $3.98M in Q2 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Charles Schwab held 78,327 shares of Precision BioSciences worth $616K as of Q2 2026.
  • Charles Schwab bought 58,327 Precision BioSciences shares in Q2 2026, an estimated $410K.
  • Precision BioSciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3179 holding.
  • Charles Schwab first reported a position in Precision BioSciences in Q2 2019 and has held it in 19 quarters since.
  • Charles Schwab's Precision BioSciences position peaked at $3.98M in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.